Ginkgo Bioworks Holdings DNA
NYSE DNA
$13.20 +1.24 (+10.37%)
As of: Sep 30, 2026 · 3:25 PM EDT

Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020)

Updated

Ginkgo Bioworks Holdings' (DNA) Debt Ratio came in at 0.00 for Q4 2020.

Analysis

Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Iqvia Holdings 44.30 Bn 36.13 Bn 1.44 Bn 0.54
2 Medpace Holdings 17.36 Bn 15.43 Bn 201.64 Mn -
3 Charles River Laboratories International 14.14 Bn 13.38 Bn 363.37 Mn 0.35
4 Icon 13.04 Bn 10.15 Bn 479.29 Mn 0.21
5 Fortrea Holdings 1.88 Bn 1.26 Bn 139.20 Mn 0.39
6 Ginkgo Bioworks Holdings 762.62 Mn 537,907.95 18.44 Mn -
7 Evotec SE 583.11 Mn -990.11 Mn - 0.26
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn -
9 MindWalk Holdings 64.46 Mn 28.68 Mn 1.61 Mn -
10 Natural Alternatives International 8.86 Mn -19.22 Mn 1.73 Mn 0.15
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 0.00
API Access

Ginkgo Bioworks Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DNA&period=max&api_key=YOUR_API_KEY